Evidence-Based Dampness-Heat ZHENG(Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor

Cancer is one of the deadliest diseases affecting the health of human beings. With limited therapeutic options available, complementary and alternative medicine has been widely adopted in cancer management and is increasingly becoming accepted by both patients and healthcare workers alike. Chinese medicine characterized by its unique diagnostic and treatment system is the most widely applied complementary and alternative medicine. It emphasizes symptoms and ZHENG(syndrome)-based treatment combined with contemporary disease diagnosis and further stratifies patients into individualized medicine subgroups. As a representative cancer with the highest degree of malignancy, pancreatic cancer is traditionally classified into the "amassment and accumulation". Emerging perspectives define the core pathogenesis of pancreatic cancer as "dampness-heat" and the respective treatment "clearing heat and resolving dampness" has been demonstrated to prolong survival in pancreatic cancer patients, as has been observed in many other cancers. This clinical advantage encourages an exploration of the essence of dampness-heat ZHENG(DHZ) in cancer and investigation into underlying mechanisms of action of herbal formulations against dampness-heat. However, at present, there is a lack of understanding of the molecular characteristics of DHZ in cancer and no standardized and widely accepted animal model to study this core syndrome in vivo. The shortage of animal models limits the ability to uncover the antitumor mechanisms of herbal medicines and to assess the safety profile of the natural products derived from them. This review summarizes the current research on DHZ in cancer in terms of the clinical aspects, molecular landscape, and animal models. This study aims to provide comprehensive insight that can be used for the establishment of a future standardized ZHENG-based cancer animal model.

中药辅助治疗的原发性肝胆恶性肿瘤的中医证型及相关因素分析

目的探讨中药辅助治疗的原发性肝胆恶性肿瘤患者的中医证型分布以及性别、年龄、手术史、治疗史、是否发生远处转移等因素与证型分布的相关性。方法回顾性分析2018年1月~2023年2月在某院住院接受中药辅助治疗的原发性肝胆恶性肿瘤患者的临床资料,用统计学软件分析中医证型的分布规律及研究一般资料、手术史、治疗史等因素与中医证型的相关情况。结果研究共纳入60例患者,中医证型分布规律为:肝郁脾虚证>气滞血瘀证>肝胆湿热证>肝肾阴虚证>水湿内停证,中医证型在化疗史、靶向治疗史、免疫治疗史、是否发生淋巴结转移的分布差异有统计学意义(P<0.05),在性别、年龄、手术史以及是否发生远处转移的分布差异无统计学意义(P>0.05)。多因素回归分析发现,是否免疫治疗是影响肝郁脾虚证的独立因素,是否化疗、是否免疫治疗以及是否淋巴结转移是影响气滞血瘀证的独立因素。结论中药辅助治疗的原发性肝胆恶性肿瘤患者的中医证型以肝郁脾虚最多,治疗史和患者是否发生淋巴结转移与中医证型分布相关,未接受免疫治疗的患者易发展为肝郁脾虚证,接受化疗或免疫治疗易导致患气滞血瘀证的风险增加。

Effective Common Chinese Herbal Medicines Used in Treating Chronic Cholecystitis with Liver-Gallbladder Dampness-Heat Syndrome: A Review of Clinical Studies in the Past 10 Years

The objective of the study is to identify the effective common Chinese herbal medicines used in treating chronic cholecystitis with liver-gallbladder dampness-heat syndrome(CCLGDHS) through reviewing relevant clinical studies published in the past 10 years. Data were collected from Science Direct and Chinese National Knowledge Infrastructure. Data screening was carried out for the abstracts and full texts of the data. The top 15 Chinese herbal medicines with the highest occurring frequency were selected, statistically analyzed, and classified by their medicinal properties, actions, and indications according to the Chinese Pharmacopoeia 2015 edition. The top 15 effective common Chinese herbal medicines comprise Chai Hu, Huang Qin, Jin Qian Cao, Bai Shao, Yin Chen, Yu Jin, Chuan Lian Zi, Yan Hu Suo, Zhi Shi, Ban Xia, Bai Zhu, Pu Gong Ying, Gan Cao, Zhi Zi, and Qing Pi. The predominant natures were cold, cool, and warm. This combination can clear stagnant heat, warm Yang, and regulate Qi dynamics. In addition, bitter, pungent, and sweet were the predominant flavors. They can clear dampness-heat, regulate Qi dynamics to relieve cramps and pain, as well as tonify the deficiency. Along with entering the liver and gallbladder meridians, these herbal medicines also entered the spleen, stomach, and lung meridians to prevent potential disease transmission. The combinatorial medicinal actions of the effective common Chinese herbal medicine highlight the importance of the holistic concept of traditional Chinese medicine when treating CCLGDHS. In addition, the inclusion of activating blood to promote blood circulation, relieving cramps and alleviating pain, and tonifying the spleen and stomach represents a new finding in the treatment principle for CCLGDHS.

金橘胆胃丸治疗老年慢性胆囊炎伴胆结石临床疗效观察

目的观察金橘胆胃丸治疗老年慢性胆囊炎伴胆结石临床效果。方法研究纳入老年慢性胆囊炎伴胆结石合计102例(2019年3月—2022年3月收治),将本次纳入患者以随机数字表法分成对照组与观察组,每组51例,对照组接受熊去氧胆酸胶囊+头孢地尼胶囊治疗,观察组接受熊去氧胆酸胶囊及头孢地尼胶囊+金橘胆胃丸治疗,两组均治疗2个月。数据观察:疗效、中医证候(右上腹阵发性绞痛、胸闷纳呆、口苦口黏、恶心呕吐、目发黄等)积分变化及肝胆功能指标变化、结石直径及胆囊壁厚度变化、炎症因子指标变化、不良反应。结果观察组治疗总有效率(96.08%,49/51)比对照组(82.35%,42/51)更高,P<0.05;治疗前,两组患者中医证候(右上腹阵发性绞痛、胸闷纳呆、口苦口黏、恶心呕吐、目发黄等)积分、总胆固醇(TC)、总胆红素(TBiL)等肝胆功能指标、结石直径及胆囊壁厚度、白细胞介素6(IL-6)及肿瘤坏死因子等指标比较,P>0.05,治疗后各组患者中医证候(右上腹阵发性绞痛、胸闷纳呆、口苦口黏、恶心呕吐、目发黄等)积分、TC、TBiL、结石直径及胆囊壁厚度、IL-6、肿瘤坏死因子等指标均改善,观察组治疗后中医证候(右上腹阵发性绞痛、胸闷纳呆、口苦口黏、恶心呕吐、目发黄等)积分、TC、TBiL、结石直径及胆囊壁厚度、IL-6、肿瘤坏死因子等指标均优于对照组,P<0.05;两组不良反应均较少,P>0.05。结论金橘胆胃丸治疗老年慢性胆囊炎伴胆结石临床效果显著,可促进结石消溶及排出,改善患者肝胆功能,安全可靠,值得应用。

Efficacy and Safety of Guihuang Formula in Treating Type Ⅲ Prostatitis Patients with Dampness-Heat and Blood Stasis Syndrome: A Randomized Controlled Trial

Objective: To observe the efficacy and safety of Guihuang Formula(GHF) in treating patients with type Ⅲ prostatitis and Chinese medicine syndrome of dampness-heat and blood stasis. Methods: Sixty-six type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome were randomly divided into the treatment group(GHF) and the control group(tamsulosin) using a random number table, with 33 cases each group. The treatment group received GHF twice a day, and the control group received tamsulosin 0.2 mg once daily before bedtime. Patients in both groups received treatment for 6 weeks and was followed up for 2 weeks. The outcomes included the National Institute of Health Chronic Prostatitis Symptom Index(NIH-CPSI) score, Chinese Medicine Symptoms Score(CMSS), expressed prostatic secretions(EPS) and adverse events(AEs). Results: After treatment, the NIH-CPSI total score and domain scores of pain discomfort, urination and quality of life decreased significantly from the baseline in both groups(P<0.05). The CMSS score decreased in both groups(P<0.05). The white blood cell(WBC) count decreased and lecithin body count increased in both groups(P<0.05). GHF showed a more obvious advantage in reducing the pain discomfort and quality of life domain scores of NIH-CPSI, reducing the CMSS score, increasing the improvement rate of the WBC and lecithin body counts, compared with the control group(P<0.05). There were no significant differences in decreasing urination domain score of NIH-CPSI between two groups(P>0.05). In addition, no serious AEs were observed. Conclusion: GHF is effective in treating type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome without serious AEs.(Registration No. ChiCTR1900026966)

Haoqin Qingdan Decoction(蒿芩清胆汤)and Ribavirin Therapy Downregulate CD14 and Toll-Like Receptor 4 in Febrile Disease with Dampness-Heat Syndrome in A Mouse Model

Objective： To evaluate the effect of Chinese medicine Haoqin Qingdan Decoction （蒿芩清胆汤, HQD） for febrile disease dampness-heat syndrome （FDDHS）. Methods： Forty mice were divided into four groups, including normal control, FDDHS （induced by Radix et Rhizoma Rhei recipe and influenza virus A1 FM1 model）, HQD, and the ribavirin groups （10 in each）. The normal control and FDDHS groups were administered normal saline. HQD and the ribavirin groups were administered HQD and ribavirin intragastrically once daily at a dose of 64 g/（kg.d） and 0.07 g/（kg.d）, respectively for 7 days. Lethargy, rough hair, diarrhea, tongue color and sole color were evaluated for pathological changes in morphology. The tongue and lung tissues were collected for histology. The CD14 and toll-like receptor 4 （TLR4） expression levels were measured using real-time quantitative polymerase chain reaction. Results： More than 80% of the FDDHS mice showed hypokinesia and lethargy, and pathological changes associated with rough hair, diarrhea, tongue color and sole color. With advanced treatment for 7 days, the thick greasy tongue fur of the HQD and ribavirin groups were thinner than that of the FDDHS group （P〈0.05）, and it was the thinnest in the ribavirin group as compared with that in other groups （P〈0.05）. The CD14 and TLR4 expression levels in the lung tissues of HQD and ribavirin groups significantly delined compared with the model group （P〈0.05 or P〈0.01）. CD14 was down-regulated more remarkably in the HQD group compared with the ribavirin group （P〈0.05）, whereas the converse was true with TLR4 （P〈0.05）. Conclusions： We established a FDDHS mouse model showing systemic clinical symptoms. Both HQD and ribavirin can inhibit the expression of CD14 and TLR4 in FDDHS mice, while the effect of ribavirin might be much more violent. The expression changes of CD14 and TLR4 consistently refers to lipopolysaccharide, the commonly and hotly inducing factor in FDDHS.

复方中草药制剂对草鱼肝胆综合症的防治研究

试验以患肝胆综合症的草鱼(C tenopharyngodon idellus)种苗为研究对象,选用复方中草药制剂为试验药物,设置3个质量分数分别为0.50%、0.75%和1.00%的复方中草药药饵组,1个不含该复方制剂的常规饲料组,1个青饲料组,饲喂4周;结合组织病理学方法,探讨了草鱼肝胆综合症的病理及复方中草药制剂对该病的治疗效果。结果表明,草鱼病变肝组织出现大片自溶性坏死和弥散性病变,肝细胞核偏移,发生空泡变性和水样变性;0.50%、0.75%和1.00%3个药饵试验组与青饲料和不含药物这2个非药饵对照组中,患病草鱼的成活率分别为60.0%、80.0%、96.7%、36.7%和16.7%。试验组草鱼比对照组草鱼肝胆综合症症状有明显好转,表现为鱼的体色、体表粘液和肝脏形态、色泽、质地恢复正常;背鳍、尾鳍边缘发白以及鳃部淤血、充血现象消失,鳃部粘液明显减少。1.00%试验组草鱼肝脏肝小叶分界清楚,肝细胞之间的界限清晰可见,肝细胞的核膜与核仁容易辨认,肝细胞核位移细胞中部,肝细胞逐渐恢复正常。

胆石片治疗不伴有胆囊结石的慢性胆囊炎(肝胆气郁证)的随机双盲对照临床试验研究

目的评价胆石片治疗不伴有胆囊结石的慢性胆囊炎(肝胆气郁证)的有效性和安全性。方法采用随机、双盲、安慰剂平行对照、多中心临床试验设计。120例不伴有结石的慢性胆囊炎患者符合本试验纳入标准,试验组和对照组各60例。分别采用胆石片(6粒/次,3次/d)及胆石片安慰剂(6粒/次,3次/d)进行为期4周的治疗。以中医证候积分(包括右胁胀痛、口苦、咽干、嗳气、恶心、厌食油腻、纳食减少、胃脘痞满、上腹饱胀、右上腹部压痛和大便秘结)和腹部超声检查进行疗效评价。以血、尿、大便常规,肝功能(ALT、AST、TBIL、DBIL)、肾功能(Bun、Cr)和心电图检查结果作为安全性评价的依据。结果治疗4周后,经CMH卡方检验,两组主要疗效、次要疗效及影像学疗效中痊愈率、显效率、有效率、无效率及总有效率比较差异有统计学意义(P<0.01)。安全性:两组均无严重不良事件发生。结论胆石片能有效治疗不伴有胆囊结石的慢性胆囊炎,并有良好的安全性。

肝胆断层显像和γ-谷胺酰转肽酶对婴儿持续性黄疸的鉴别诊断价值

目的探讨99Tcm-二乙基乙酰苯胺亚氨二醋酸(99Tcm-EHIDA)肝胆断层显像和γ-谷胺酰转肽酶(γ-GT)对婴儿持续性黄疸的鉴别诊断价值。方法肝胆动态平面显像1h内未见明确肠道放射性出现的127例持续性黄疸患儿,6～8h进行肝胆断层显像及滤波反投射三维重建,排除体表及其他脏器放射性干扰的基础上,重点观察有无肠道放射性出现和功能性胆囊显影,所有患儿进一步接受24h肝胆平面延迟显像和显像前血清γ-GT测定,参照临床最终诊断评价其诊断效能和联合应用价值。结果99Tcm-EHIDA肝胆平面显像诊断先天性胆道闭锁(BA)和婴儿肝炎综合征(IHS)的灵敏度、特异性、准确性、阳性预测价值、阴性预测价值分别为85.7%、59.8%、71.7%、49.2%、91.7%和59.8%、85.7%、71.7%、91.7%、49.2%;联合6～8h肝胆断层显像,诊断BA和IHS的灵敏度、特异性、准确性、阳性预测价值、阴性预,测价值分别提高至97.1%、73.9%、80.3%、58.6%、98.6%和73.9%、97.1%、80.3%、98.6%、58.6%。对日龄<60d组,以γ-GT≥300U/L作为BA的诊断标准,诊断BA和IHS的灵敏度、特异性、准确性分别为60.9%、87.7%、80.0%和87.7%、60.9%、80.0%。对日龄<60d,肝胆显像(平面加断层,以下简称肝胆联合显像)持续未见功能性胆囊影和(或)肠道放射性的37例患儿,联合检测血清γ-GT,对BA的诊断特异性和对IHS的诊断灵敏度均提高至91.2%。结论99Tcm-EHIDA肝胆断层显像对BA和IHS的诊断效能明显高于24h延迟平面显像,对日龄<60d者,肝胆联合显像和血清γ-GT具有较好的联合应用价值。

胆道闭锁和婴儿肝炎综合征影像学诊断和鉴别诊断

胆道闭锁(BA)预后与手术日龄密切相关,早期诊断并同婴儿肝炎综合征(IHS)等鉴别极为重要。主要影像学诊断方法是超声显像(US)、磁共振成像(MRCP)、胆管造影及放射性核素肝胆显像(HBS)等。这些检查方法既有各自独特的优势,也有其相应不足。US对BA的特异性和对IHS灵敏度较高,但对BA的灵敏度较低;而肝胆显像对BA的诊断具有极高的灵敏度,其特异性受胆汁淤积等影响较大;MRCP能显示胆管结构,但受其条件、设备影响;胆管造影虽为金标准,但难度和创伤性较大。本文将BA和IHS影像学诊断、鉴别诊断及其进展综述如下。

慢性乙型肝炎肝胆湿热证与肝功能指标相关性的Meta分析

目的:探讨慢性乙型肝炎肝胆湿热证患者与其血清ALT、TBil含量的相关性,为慢性乙型肝炎中医辨证客观化研究提供新思路。方法:通过计算机检索CAJD、CBM、CDFD、CMFD以及PubMed等数据库,检索时间从1993年1月至2013年12月;按照纳入和排除标准筛选文献、提取资料并根据按实际情况制定出的质量评价标准进行评价后,采用RevMan 5.2软件进行Meta分析。结果:共纳入10篇文献,2 244例患者。Meta分析结果显示:肝胆湿热证型与ALT[SMD=0.36,95%CI(0.20,0.52),P<0.0001]、与TBil[SMD=0.51,95%CI(0.33,0.69),P<0.00001]间均存在明显的相关性。结论:慢性乙型肝炎肝胆湿热证型组与肝郁脾虚证型组相比较,患者血清ALT、TBil含量明显升高。

草鱼肝胆综合症并发细菌疾病病原分离鉴定及药敏试验

对2016年6月江西省鄱阳县高家岭一个养殖场养殖草鱼发生的暴发性疾病进行病原分离鉴定及药敏试验,旨在确定其病因,为今后生产中有效防控该疾病提供参考。利用细菌分离方法在无菌条件下从患肝胆综合症草鱼体内分离、纯化致病菌,通过形态学、生化鉴定和16SrDNA序列分析、gyrB基因序列分析进行菌株鉴定,用攻毒试验找出草鱼的半致死浓度,并采用滤纸片扩散法进行药敏试验。从患肝胆综合症草鱼体内分离、纯化到一株致病菌,经鉴定为维氏气单胞菌,命名为PYG1。攻毒试验表明该菌能感染草鱼,且半致死浓度为1.5×10~4CFU/g鱼体质量。药敏试验结果表明该菌只对氨基糖苷类、第二代和第三代头孢类以及喹诺酮类的氧氟沙星共9种药物表现出敏感或中度敏感,对所测的其他药物耐药,为强耐药菌株。维氏气单胞菌PYG1是引起此次草鱼发病的致病菌,可选用氨基糖苷类、头孢类及喹诺酮类的氧氟沙星等药物进行防治。

中医护理在肝胆胰外科术后疲劳综合征患者中的应用

目的探讨肝中医护理在胆胰患者外科手术之后疲劳综合征患者中的应用效果。方法选取2016年4月至2017年4月治疗的的肝胆胰患者140例作为研究对象,随机等分为对照组和观察组。对照组采用常规护理,研究组手术之后采用中医护理。分别在手术前、手术后3,7d时记录下两组患者的转铁蛋白水平变化;比较两组患者术后首次下床排气时间和住院时间。结果经过一段时间的护理治疗后,研究组患者的转铁蛋白水平变化情况显著高于对照组(P <0. 05);研究组患者的首次下床时间、排气时间和住院时间显著短于对照组(P <0. 05)。结论将中医护理用于肝胆胰外科术后疲劳综合征患者中有助于减轻患者的疲劳程度,值得在临床上进一步推广。

肝脏/心脏比值对肝胆显像诊断胆道闭锁的影响

目的探讨行肝胆平面显像患儿肝脏与心脏的平均计数比值(liver-to-heart ratio,L/H)对诊断结果的影响。方法收集2012年1月~2013年2月间因黄疸于本院行肝胆平面显像新生儿患儿90例,其中65例通过手术病理确诊,25例通过临床随访确诊。回顾性分析所有图像特点,测量并计算每个患儿注射药物后10 min的L/H比值。根据L/H大小,将患儿分为A组(L/H≥1.72)和B组(L/H<1.72),比较两组患儿肝胆动态显像诊断或排除胆道闭锁的正确率。结果 A组患儿肝胆平面显像诊断及排除先天性胆道闭锁的正确率明显高于B组,差异有统计学意义(P<0.05)。结论通过计算肝胆显像10 min的L/H比值,可以直观并且半定量评估图像,尤其要注意L/H比值较低的患儿。

中医护理在肝胆胰外科手术后疲劳综合征患者中的应用

目的着重分析肝中医护理在肝胆胰外科术后疲劳综合征患者中的实际应用效果。方法选取某院2018年6月—2019年6月的140例患者作为主要研究对象,将他们随机分为对照组与研究组。对于对照组的患者采用相对常规的护理方式,而对研究组采用中医护理的方式。分别在手术中、手术后对2组患者的术后首次下床排气时间以及住院时间进行记录。结果在经过一段时间的治疗与护理之后,研究组患者的转铁蛋白水平要明显高于对照组。另外,研究组患者的首次下床时间、住院时间等等都要明显短于对照组。结论对肝胆胰外科手术后疲劳综合征的患者使用中医护理可以有效缓解患者的疲劳程度,由此可知,这种护理方式是可以进行广泛推广的。

32例婴儿黄疸99mTc-EHIDA肝胆动态显像结果分析

目的探讨99m Tc-EHIDA肝胆动态显像在先天性胆道闭锁和婴儿肝炎综合征鉴别诊断中的临床价值。方法回顾性分析32例婴儿黄疸患儿的肝胆动态显像资料及临床资料。结果 99m Tc-EHIDA肝胆显像诊断先天性胆道闭锁的特异度为100%(19/19),灵敏度为84.6%(11/13),阳性率100%(11/11),阴性率90.5%(19/21),预测准确性为93.7%(30/32)。结论99m Tc-EHIDA肝胆动态显像是一种安全、有效、无创性的检查方法,对于先天性肝胆闭锁和婴儿肝炎综合征的鉴别诊断有较高的临床价值。

Ultrastructure Characteristics of Different Chinese Medicine Syndromes of Helicobacter pylori-Correlated Gastric Diseases

Objective: To explore the ultrastructure characteristics of patients with dampness-heat of Pi(Spleen)-Wei(Stomach) syndrome(DHPW) and Pi-qi deficiency syndrome(PQD), both of which are Helicobacter pylori(Hp)-correlated gastric diseases(HPCG), and implicate a helpful hint for the clinical microcosmic syndrome differentiation. Methods: Fourteen gastric mucosa samples from 6 chronic gastritis(CG) and 6 active peptic ulcer(including 8 DHPW, 4 PQD) as well as 2 healthy volunteers were collected and tested for Hp infection. The ultrastructure of gastric mucosa was observed under the transmission electron microscope(TEM). Results: Among 14 gastric mucosa samples, 8 of them were Hp positive(6 DHPW and 2 PQD), which were all accordance with the results screened by supermicro-pathological method. Under TEM, the normal gastric mucosa, with tidy microvilli and abundant in mucus granules, mitochondria and rough endoplasmic reticulum distributed evenly, and with smooth nucleus membrane. But in those specimens of DHPW with Hp infection, microvilli were presented with burr shape. Especially, those samples from dampnessheat syndrome with predominant heat type(DHSH) patients were more obvious, with microvilli damaged, mitochondria concentrated and distributed in disorder, secretory tubule extended. In dampness-heat syndrome with predominant dampness type(DHSD) patients, mucus granules aggregated obviously, mitochondria swelled and blurred, and rough endoplasmic reticulum crowded. For 2 samples of DHPW without Hp infection, their microvilli were intact, with mitochondria increased and gathered but well-distributed, and secretory tubule extended mildly. In 2 PQD patients with Hp positive, the specimens of microvilli were sparse, and their mucus granules and mitochondria were decreased, with fractured crests and vacuole, secretory tubules extension to nucleus membrane, and rough endoplasmic reticulum extension in a pool-like way, and nucleus condensed. The 2 samples from PQD patients without Hp infection were characterized with intact microvilli, decreased mitochondria, fractured crest and extended rough endoplasmic reticulum in a pool-like way. Conclusion: It is obvious different in ultrastructure of DHPW and PQD patients under TEM, which may give a helpful hint for the microcosmic syndrome differentiation of HPCG.

一贯煎在肝胆病中的运用

一贯煎是疏肝滋阴的名方,"肝为五脏之贼,肝病如邪",慢性肝炎、肝硬化、肝癌、胆结石、胆囊炎等肝胆病严重危害现代人的健康,结合临床,对一贯煎在肝胆病中的应用和心得体会进行总结,从一贯煎方名由来、一贯煎组方分析,到临床应用及治法治则,认为治疗慢性肝炎,重在滋养肝肾;治疗老年性肝炎,养阴法为关键;治疗乙型肝炎,宜肝肾同补;治疗肝硬化,疏泄为主,气血兼顾;辅助治疗肝癌,疏肝行气,化痰散结止痛;治疗胆石症,疏肝解郁,利胆通腑;治疗胆囊炎,滋阴养血,柔肝利胆。用药体会是:用药加减恰当,注意通权达变;注重脏腑制化关系,酌情遣方用药;治病为本,合理变通;注重辩证,异病同治。

仲景治黄组方现代应用总结

黄疸分为多种证型,每种证型都对应的独特治疗方法,历代医家对黄疸的治疗有自己的见解。张仲景于《伤寒杂病论》中颇为详细地论述了治黄八法,直到现在对于现代临床医学的发展仍具有重要指导意义,为后世医家将八法应用于临床提供理论基础。近代以来,随着医疗技术的进步及祖国医学的蓬勃发展,医者将西药与中药联合起来治疗疾病已屡见不鲜,证明中医药对于疾病的治疗大有益处。现总结近年来临床研究应用情况,以供临床参考。

中西医结合治疗葡萄膜炎(VKH综合征-肝胆火炽型)的临床观察

目的:探讨中西医结合治疗葡萄膜炎(VKH综合征-肝胆火炽型)的临床疗效。方法:将46例患者随机分为对照组(激素) 23例和治疗组(激素+中药) 23例,比较治疗前后最佳矫正视力的变化及治疗后的综合疗效,并进行统计学分析。结果中西医结合治疗组治疗后最佳矫正视力(0. 58±0. 14),对照组(0. 49±0. 13),P <0. 05;综合有效率治疗组95. 65%,对照组86. 96%, P <0. 05。结论中西医结合治疗有助于视力恢复,和缓症状,临床效果显著。